276 related articles for article (PubMed ID: 32328192)
21. Expression of Long Noncoding RNA Urothelial Cancer Associated 1 Promotes Cisplatin Resistance in Cervical Cancer.
Wang B; Huang Z; Gao R; Zeng Z; Yang W; Sun Y; Wei W; Wu Z; Yu L; Li Q; Zhang S; Li F; Liu G; Liu B; Leng L; Zhan W; Yu Y; Yang G; Zhou S
Cancer Biother Radiopharm; 2017 Apr; 32(3):101-110. PubMed ID: 28414550
[TBL] [Abstract][Full Text] [Related]
22. Exosomal lncRNA UCA1 Derived From Pancreatic Stellate Cells Promotes Gemcitabine Resistance in Pancreatic Cancer
Chi Y; Xin H; Liu Z
Front Oncol; 2021; 11():671082. PubMed ID: 34868904
[TBL] [Abstract][Full Text] [Related]
23. Long non-coding RNA PICART1 inhibits cell proliferation by regulating the PI3K/AKT and MAPK/ERK signaling pathways in gastric cancer.
Li JF; Li WH; Xue LL; Zhang Y
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):588-597. PubMed ID: 30720166
[TBL] [Abstract][Full Text] [Related]
24. Suppression of long non-coding RNA UCA1 inhibits proliferation and invasion and induces apoptosis in human lung cancer cells.
Jun T; Zheng FS; Ren KM; Zhang HY; Zhao JG; Zhao JZ
Eur Rev Med Pharmacol Sci; 2018 Nov; 22(21):7274-7281. PubMed ID: 30468471
[TBL] [Abstract][Full Text] [Related]
25. Decreased expression of the long non-coding RNA
Yao L; Ye PC; Tan W; Luo YJ; Xiang WP; Liu ZL; Fu ZM; Lu F; Tang LH; Xiao JW
World J Gastrointest Oncol; 2020 Nov; 12(11):1237-1254. PubMed ID: 33250958
[TBL] [Abstract][Full Text] [Related]
26. Dysregulated lncRNA-UCA1 contributes to the progression of gastric cancer through regulation of the PI3K-Akt-mTOR signaling pathway.
Li C; Liang G; Yang S; Sui J; Yao W; Shen X; Zhang Y; Peng H; Hong W; Xu S; Wu W; Ye Y; Zhang Z; Zhang W; Yin L; Pu Y
Oncotarget; 2017 Nov; 8(55):93476-93491. PubMed ID: 29212166
[TBL] [Abstract][Full Text] [Related]
27. Augmented expression levels of lncRNAs
Nasrollahzadeh-Khakiani M; Emadi-Baygi M; Nikpour P
Iran J Basic Med Sci; 2017 Oct; 20(10):1149-1158. PubMed ID: 29147491
[TBL] [Abstract][Full Text] [Related]
28. lncRNA UCA1 Predicts a Poor Prognosis and Regulates Cell Proliferation and Migration by Repressing p21 and SPRY1 Expression in GC.
He X; Wang J; Chen J; Han L; Lu X; Miao D; Yin D; Geng Q; Zhang E
Mol Ther Nucleic Acids; 2019 Dec; 18():605-616. PubMed ID: 31689615
[TBL] [Abstract][Full Text] [Related]
29. Knockdown of Long Non-Coding RNA UCA1 Increases the Tamoxifen Sensitivity of Breast Cancer Cells through Inhibition of Wnt/β-Catenin Pathway.
Liu H; Wang G; Yang L; Qu J; Yang Z; Zhou X
PLoS One; 2016; 11(12):e0168406. PubMed ID: 27977766
[TBL] [Abstract][Full Text] [Related]
30. LncRNA RP11-93B14.5 promotes gastric cancer cell growth through PI3K/AKT signaling pathway.
Li Q; Zhu Z; Zhang H; Wu X; Yang H; Li X; Li W; Zhao Y; Du F; Chen Y; Shen J; Xiao Z; Chen M; Wang F; Gu L; Sun Y; Lu L; Jia Y; Li M
Mol Biotechnol; 2023 Sep; ():. PubMed ID: 37682457
[TBL] [Abstract][Full Text] [Related]
31. Elevated lncRNA-UCA1 upregulates EZH2 to promote inflammatory response in sepsis-induced pneumonia via inhibiting HOXA1.
Zhang X; Tang X; Pan L; Li Y; Li J; Li C
Carcinogenesis; 2022 May; 43(4):371-381. PubMed ID: 35018436
[TBL] [Abstract][Full Text] [Related]
32. Apoptin-derived peptide reverses cisplatin resistance in gastric cancer through the PI3K-AKT signaling pathway.
Zhou D; Liu W; Liang S; Sun B; Liu A; Cui Z; Han X; Yuan L
Cancer Med; 2018 Apr; 7(4):1369-1383. PubMed ID: 29522284
[TBL] [Abstract][Full Text] [Related]
33. LncRNA UCA1 Promotes Mitochondrial Function of Bladder Cancer via the MiR-195/ARL2 Signaling Pathway.
Li HJ; Sun XM; Li ZK; Yin QW; Pang H; Pan JJ; Li X; Chen W
Cell Physiol Biochem; 2017; 43(6):2548-2561. PubMed ID: 29130995
[TBL] [Abstract][Full Text] [Related]
34. Downregulation of lncRNA UCA1 facilitates apoptosis and reduces proliferation in multiple myeloma via regulation of the miR-1271-5p/HGF axis.
Yang Y; Chen L
J Chin Med Assoc; 2019 Sep; 82(9):699-709. PubMed ID: 31356563
[TBL] [Abstract][Full Text] [Related]
35. AFAP1-AS1 induces cisplatin resistance in non-small cell lung cancer through PI3K/AKT pathway.
Liu Y; Hu Q; Wang X
Oncol Lett; 2020 Jan; 19(1):1024-1030. PubMed ID: 31897216
[TBL] [Abstract][Full Text] [Related]
36. UCA1 promotes cell proliferation and invasion and inhibits apoptosis through regulation of the miR129-SOX4 pathway in renal cell carcinoma.
Liu Q; Li Y; Lv W; Zhang G; Tian X; Li X; Cheng H; Zhu C
Onco Targets Ther; 2018; 11():2475-2487. PubMed ID: 29760557
[TBL] [Abstract][Full Text] [Related]
37. Long Non-Coding RNA UCA1 Modulates Paclitaxel Resistance in Breast Cancer via miR-613/CDK12 Axis.
Liu C; Jiang F; Zhang X; Xu X
Cancer Manag Res; 2020; 12():2777-2788. PubMed ID: 32425595
[TBL] [Abstract][Full Text] [Related]
38. Involvement of SRPK1 in cisplatin resistance related to long non-coding RNA UCA1 in human ovarian cancer cells.
Wang F; Zhou J; Xie X; Hu J; Chen L; Hu Q; Guo H; Yu C
Neoplasma; 2015; 62(3):432-8. PubMed ID: 25967360
[TBL] [Abstract][Full Text] [Related]
39. Metformin Suppresses the Proliferation and Promotes the Apoptosis of Colon Cancer Cells Through Inhibiting the Expression of Long Noncoding RNA-UCA1.
Guo J; Li Y; Duan H; Yuan L
Onco Targets Ther; 2020; 13():4169-4181. PubMed ID: 32523353
[TBL] [Abstract][Full Text] [Related]
40. Mechanistic study of lncRNA UCA1 promoting growth and cisplatin resistance in lung adenocarcinoma.
Fu J; Pan J; Yang X; Zhang Y; Shao F; Chen J; Huang K; Wang Y
Cancer Cell Int; 2021 Sep; 21(1):505. PubMed ID: 34544452
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
